Find uplifting stories about heroes, innovations, and solutions
3 results for "johnson & johnson"
A new once-daily pill just became the first FDA-approved oral peptide treatment for moderate-to-severe plaque psoriasis, offering hope to millions who've struggled with painful skin lesions. The breakthrough medication cleared or nearly cleared skin in 70% of patients during clinical trials.
Johnson & Johnson just won approval for the first daily pill that matches the power of injectable psoriasis treatments. The breakthrough could help millions who avoid shots and reshape how we treat this painful skin condition.
A new cell therapy manufacturing plant will bring life-saving medical innovation and hundreds of high-skilled jobs to Montgomery County by 2031. The facility represents a major win for Pennsylvania's growing life sciences industry.